BIBDX
Price
$11.88
Change
+$0.10 (+0.85%)
Updated
Jul 31 closing price
Net Assets
829.24M
RSEYX
Price
$14.22
Change
-$0.03 (-0.21%)
Updated
Jul 31 closing price
Net Assets
893.16M
Interact to see
Advertisement

BIBDX vs RSEYX

BIBDX vs RSEYX Comparison Chart in %
View a ticker or compare two or three
VS
BIBDX vs. RSEYX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIBDX is a Hold and RSEYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSEYX has more cash in the bank: 893M vs. BIBDX (829M). RSEYX pays higher dividends than BIBDX: RSEYX (3.29) vs BIBDX (1.25). BIBDX was incepted earlier than RSEYX: BIBDX (18 years) vs RSEYX (20 years). RSEYX (0.82) and BIBDX (0.80) have similar cost to investors . RSEYX is a more actively managed with annual turnover of: 63.00 vs. BIBDX (44.00). RSEYX has a lower initial minimum investment than BIBDX: RSEYX (0) vs BIBDX (2000000). RSEYX annual gain was more profitable for investors over the last year : 9.13 vs. BIBDX (-3.92). RSEYX return over 5 years is better than : 20.05 vs. BIBDX (2.74).
BIBDXRSEYXBIBDX / RSEYX
Total Expense Ratio0.800.8298%
Annual Report Gross Expense Ratio0.800.8298%
Fund Existence18 years20 years-
Gain YTD1.2188.31315%
Front LoadN/AN/A-
Min. Initial Investment20000000-
Min. Initial Investment IRAN/AN/A-
Net Assets829M893M93%
Annual Yield % from dividends1.253.2938%
Returns for 1 year-3.929.13-43%
Returns for 3 years8.3928.9429%
Returns for 5 years2.7420.0514%
Returns for 10 years17.4650.6035%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DBOCX25.380.10
+0.40%
BNY Mellon Balanced Opportunity C
DRRAX17.660.02
+0.11%
BNY Mellon Global Real Return - A
VZICX38.380.03
+0.08%
Vanguard International Core Stock Adm
PFPMX41.20-0.04
-0.10%
Parnassus Mid Cap Institutional
LYFIX17.94-0.50
-2.71%
AlphaCentric Life Sciences & Hlthcare I